mdl 100173 has been researched along with atrial natriuretic factor in 2 studies
| Studies (mdl 100173) | Trials (mdl 100173) | Recent Studies (post-2010) (mdl 100173) | Studies (atrial natriuretic factor) | Trials (atrial natriuretic factor) | Recent Studies (post-2010) (atrial natriuretic factor) |
|---|---|---|---|---|---|
| 7 | 2 | 0 | 15,455 | 1,105 | 1,760 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, BA; Dage, RC; Downs, TR; French, JF | 1 |
| Anderson, B; Beach, DC; Dage, RC; Flynn, GA; French, JF; Giroux, EL; Koehl, JR; Mehdi, S | 1 |
2 other study(ies) available for mdl 100173 and atrial natriuretic factor
| Article | Year |
|---|---|
Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase in rats with hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Benzazepines; Blood Pressure; Captopril; Disease Models, Animal; Diuresis; Hypertension; Hypertension, Renal; Male; Neprilysin; Protease Inhibitors; Pyridines; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Sodium | 1995 |
Characterization of a dual inhibitor of angiotensin I-converting enzyme and neutral endopeptidase.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Benzazepines; Bradykinin; Male; Molecular Structure; Neprilysin; Peptidyl-Dipeptidase A; Prodrugs; Pyridines; Rats; Rats, Sprague-Dawley | 1994 |